Composti di ricerca di grado farmaceutico
Buy libido and vitality research peptides online — PT-141 (Bremelanotide) and Kisspeptin-10 — at ≥99% HPLC purity with full Certificate of Analysis. This category covers the two canonical research tools at the intersection of sexual-health biology and peptide pharmacology. PT-141 is a melanocortin-4 receptor (MC4R) agonist derived from alpha-MSH, acting on central nervous system pathways rather than peripheral vasodilation — uniquely distinct from PDE5-inhibitor research compounds. Kisspeptin-10 is the C-terminal fragment of kisspeptin-54, the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis, triggering GnRH release and downstream LH/FSH/sex-steroid cascade. Both compounds have 15+ years of research literature and are central to research into sexual response biology, HPG-axis function, and hypothalamic neuropeptide signaling. Every batch is synthesized under cGMP conditions and ships with reconstitution and handling documentation.
PT-141 (Bremelanotide) is an MC4R agonist that acts on hypothalamic and CNS pathways. Unlike PDE5 inhibitors which act on peripheral vasodilation, PT-141's mechanism is central — sexual-response regulation originates in the brain. FDA-approved for HSDD research in women (Vyleesi); extensive male-model data as well.
Kisspeptin is the apex hypothalamic neuropeptide regulating reproductive hormone signaling. Kisspeptin-10 (the bioactive C-terminal fragment) stimulates GnRH neuron firing, driving LH and FSH release and the sex-steroid cascade. Essential research tool for HPG-axis function studies.
PT-141 is also available as a nasal spray format, reflecting the original research delivery route and bypassing first-pass metabolism. Both nasal and subcutaneous administration are documented in research literature, with the route choice depending on the pharmacokinetic profile the protocol targets.
Libido and HPG-axis research intersects with sleep, stress, and metabolic biology. Protocols commonly measure testosterone, LH, FSH, cortisol, and sleep architecture alongside sexual-response endpoints.
PT-141 acts on central MC4R pathways in the CNS, not on peripheral vasodilation. This makes it a fundamentally different research tool than PDE5 inhibitors. Mechanistically, it addresses neurological components of sexual response rather than blood flow.
HPG-axis function studies, fertility research, GnRH-pulse characterization, and hypogonadism models. It is the most direct research tool available for probing hypothalamic reproductive signaling.
They target different pathways — PT-141 on central melanocortin signaling, Kisspeptin-10 on HPG-axis stimulation. They can be studied together but serve fundamentally different research questions and are not typically combined in the same protocol.
Showing 1–5 of 5 products
ResearchSupreme Biologics
Bremelanotide — un peptide melanocortinico ciclico studiato per i suoi effetti sulla via centrale MC3R/MC4R.
ResearchSupreme Biologics
Bremelanotide — un peptide melanocortinico ciclico studiato per i suoi effetti sulla via centrale MC3R/MC4R.
ResearchCalyssee
Bremelanotide — un peptide melanocortinico ciclico studiato per i suoi effetti sulla via centrale MC3R/MC4R.
ResearchCalyssee
Bremelanotide — un peptide melanocortinico ciclico studiato per i suoi effetti sulla via centrale MC3R/MC4R.
ResearchWolf
Bremelanotide — un peptide melanocortinico ciclico studiato per i suoi effetti sulla via centrale MC3R/MC4R.